Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype

Other users also viewed these articles

Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype–phenotype expression Christos Paliouras, Georgios Aperis, Foteini Lamprianou, Giorgos Ntetskas, Konstantinos Roufas, Polichronis Alivanis

10.1016/j.nefroe.2015.09.009

Multiple parapelvic cysts in Fabry disease María A. Azancot, Josefa Vila, Carmen Domínguez, Xavier Serres, Eugenia Espinel

10.1016/j.nefroe.2016.06.004

Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick? Hakan Ozer, Ismail Baloglu, Ali Topkac, Yasin Ozturk, Fethi Yonet, Furkan Daglı, İbrahim Kilinc, Kultigin Turkmen

10.1016/j.nefroe.2023.05.002